Therapeutic Potential of Targeting the Endocannabinoids: Implications for the Treatment of Obesity, Metabolic Syndrome, Drug Abuse and Smoking Cessation

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|13|22|2669-2680

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.22, 2006-09, pp. : 2669-2680

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Combinations for Dyslipidemia and Obesity Treatment in Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 15, Iss. 29, 2009-10 ,pp. : 3446-3462

Bentham Science Publishers

Access to resources Recommend Favorite

Relevance of Nutritional Antioxidants in Metabolic Syndrome, Ageing and Cancer: Potential for Therapeutic Targeting

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 4, 2009-08 ,pp. : 400-414

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Treatment of Metabolic Syndrome

By  

Current Clinical Pharmacology, Vol. 8, Iss. 3, 2013-08 ,pp. : 224-231

Bentham Science Publishers

Access to resources Recommend Favorite

Endocannabinoids in Appetite Control and the Treatment of Obesity

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 3, 2006-06 ,pp. : 275-292

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 22, Iss. 7, 2016-02 ,pp. : 895-903

Bentham Science Publishers

Access to resources Recommend Favorite